IHL 0.00% 4.1¢ incannex healthcare limited

General discussion, page-2252

  1. 933 Posts.
    lightbulb Created with Sketch. 1446
    Cannacord just initiated research coverage on Compass Pathways (US Psychedelics) at $80. The stock is trading at $35 which is a US$1.2 billion valuation and I’ve seen price targets up to $100.

    This is a sector that is just getting started and IHL could be the first and only ASX listed company with a psychedelics program. Strap yourself in girls and boys...
 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.